biohazard sign

The Institutional Biosafety Committee (IBC) was established under the provisions of the NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines). The role of the IBC is to establish and implement policies that provide for the safe conduct of recombinant DNA research and to ensure compliance with the NIH Guidelines. In addition, the IBC oversees research involving infectious agents and toxic biological molecules. The IBC also reviews research protocols from grant applications submitted to extramural funding agencies to confirm that experiments will be conducted safely and in compliance with the NIH Guidelines. Members of the IBC are appointed by the Vice President for Research and Biotechnology and include persons who are not otherwise affiliated with the University to represent the interests of the surrounding community with respect to health and protection of the environment.

All communication should be directed to the IBC office at:

IBC Application Form (in Word) version 11-24-2020 Note: if your IBC application has any other date, please discard that form and use the current version

Biosafety Training

Bloodborne Pathogens Exposure Control Plan

Bloodborne Pathogens Exposure Report Form

Hepatitis B Vaccination Declination Form

Aerosol Transmissible Diseases (ATD) program

Reporting Template for Incidents Involving Recombinant or Synthetic Nucleic Acid Molecules

Dual Use Research of Concern (DURC)

      Guiding Principals for Biosafety Governance

NIH Policy on Mitigating Risks (NOT-OD-13-107)

DURC Committee 

DURC Policy

Federal Select Agent Program

Identification, Assessment, Management and Responsible Communication of DURC

Case Studies


Training Slide Set


National Institutes of Health (NIH)

NIH Requirements for IBC’s

NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules

The NIH Process for Human Gene Transfer Trials- Frequently Asked Questions

Centers for Disease Control (CDC)

Biosafety in Microbiological and Biomedical Laboratories

or, view the BMBL, indexed, section-by-seciton on the CDC website

Federal Select Agent Regulations:

Possession, Use and Transfer of Select Agents and Toxins

Animals and Animal Products (9 CFR 121)

Agriculture (7 CFR 331)

Public Health (42 CFR 73)

Health and Human Services Regulations:

Interstate Shipment of Etiologic Agents (42 CFR 72)

Etiologic Agent Import Permit Program (42 CFR 71)

Department of Labor Occupational Safety & Health Administration (OSHA)

Occupational Exposure to Bloodborne Pathogens (29 CFR 1910.1030)

Bloodborne Pathogens and Needle Stick Prevention